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Numerous international and national
organizations (CIPR 1985, WHO 1988,
SFPH-SFRO 1992, AAPM 1994, ESTRO
1994, IAEA 1998, IMRT Collaborative
Group 2001 ...) recommend the practice of
in vivo dosimetry to check the global
quality of treatments by radiotherapy. This
type of dosimetry is much more difficult to
carry out for IMRT than for standard
treatments because of the numerous and
inhomogeneous beams involved (with low
dose segments and high dose gradients),
and the heterogeneity of dose within the
target volume. After having recalled the
main objectives of in vivo dosimetry
(detection of errors and dose verification),
a quick review of dosimetric detectors
susceptible to answer to problems of IMRT
is made. They should be sensitive under a
small volume, not connected to high
voltage for patient security, with a res-
ponse accurate, reproducible, independent
on dose-rate, beam direction, temperature
at least up to 42°C, and of course, be
tissue-equivalent with a low energy depen-
dence. The characteristics, advantages
and disadvantages of different detectors
such as diodes, MOSFETs, thermolu-
minescent detectors (TLD), radiochromic
films Gafchromic HS and scintillator plastic
are reviewed. Considering the particu-
larities of them, it seems that TLD be the
best suited for practice of in vivo dosimetry
in IMRT. Some examples of application
will be presented to illUstrate that They
show that tolerance values different from
those accepted for standard radiotherapy
and suited to IMRT is mandatory for a
correct exploitation of the obtained
Results. The conclusion is that practice of
in vivo dosimetry during IMRT is possible
but delicate, that TLD dosimetry is the best
suited to it but time-consuming and
relatively expansive, so that it should be
restricted to selected applications in the
frame of strict protocols in order to
optimize results and cost.
S226
112.
THE ROLE OF THE SECONDARY
STANDARD DOSIMETRY LABORA-
TORY IN THE QUALITY ASSURAN-
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In Poland, in 1937, a special measu-
rement unit was established in the Radium
Institute (former name of the Institute of
Oncology). The continuation of this unit is
the SSDL, which was established in 1966
at the Medical Physics Department (MPD)
of the Institute of Oncology. In 1988, the
Laboratory was approved as a member of
the IAEAlWHO SSDL network, and is
periodically audited by the IAEA. The
SSDL plays an important role in maintai-
ning proper dosimetry standards in radio-
therapy in Poland.
The main activities of the SSDL are:
- Collecting data concerning the infrastru-
cture of radiotherapy in Poland. This
activity started in 1993 and is continued
on the yearly basis.
- Calibration of dosimeters at the national
level; it started as early as 1937. The
SSDL calibrates over 20 ionisation
chambers each year. The Co-60
exposure calibration factors are
established, and then the air-kerma and
the absorbed dose calibration factors are
calculated. The system linearity and
energy characteristics are determined in
the orthovoltage range. In 2002 the
measurement facility for calibrating the
mammography dosimeters was set-up.
- External qualify audits . of ,dosimetry in
radiotherapy centres in Poland. During
the period 1991-2001, 151 audits, based
on TLD dose inter-comparisons were
performed in reference conditions. The
deviations above 3.5% (defined as acce-
ptance level) were observed in 18 cases
(nearly 12%). Since 2002 the audits in
more complex, non standard conditions
started.
- Preparation of protocols and recommen-
dations on dosimetry in radiotherapy.
The QC recommendations for Co-60
units and accelerators were issued
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